← SynDRA
ETICLOPRIDE
SynDRA canonical compound SYN0000312 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD2 |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- DRD2 ANTAGONIST
- DRD3 ANTAGONIST
- DRD4 ANTAGONIST
- DRD2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15B
- GLS
- TDP1
- SAMHD1
- LMNA
- IDH1
- HIF1A
- HDAC6
- GMNN
- GLP1R
- ATXN2
- GBA1
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CBX1
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP19A
- CP1A2
- CP2D6
- CP3A4
- ESR1
- KCNH2
- NR1I2
Drug classes
Cross-references
Synonyms
- Eticloprida
- Eticlopride [INN]
- Eticlopridum [Latin]
- Eticloprida [Spanish]
- CHEMBL8946
- UNII-J8M468HBH4
- J8M468HBH4
- FLB-131
- 3-Chloro-5-Ethyl-N-{[(2s)-1-Ethylpyrrolidin-2-Yl]methyl}-6-Hydroxy-2-Methoxybenzamide
- C17H25ClN2O3
- 5-chloro-3-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide
- (-)-(S)-5-Chloro-3-ethyl-N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxysalicylamide
- NCGC00016963-01
- NCGC00161393-01
- CAS-97612-24-3
- Eticlopridum
- Prestwick3_000932
- ETICLOPRIDE,S(-)
- AC1L1MN4
- FLB 131
- RefChem:139228
- DTXCID10819923
- R (+)-Eticloride hydrochloride
- BSPBio_000864
- GTPL966
- SCHEMBL572121
- BPBio1_000952
- orb2646273
- SCHEMBL30874373
- CHEBI:92874
- BDBM50007518
- PDSP1_000923
- PDSP1_001517
- PDSP2_000909
- PDSP2_001501
- NCGC00161393-02
- HY-121129
Look up ETICLOPRIDE in the interactive SynDRA portal →